{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:12:06Z","timestamp":1792012326182,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T00:00:00Z","timestamp":1457395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T00:00:00Z","timestamp":1457395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1038\/leu.2016.53","type":"journal-article","created":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T07:51:57Z","timestamp":1457423517000},"page":"1282-1289","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Aberrant activation of CaMKII\u03b3 accelerates chronic myeloid leukemia blast crisis"],"prefix":"10.1038","volume":"30","author":[{"given":"Y","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,8]]},"reference":[{"key":"BFleu201653_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrm1280","volume":"5","author":"O Hantschel","year":"2004","unstructured":"Hantschel O, Superti-Furga G . Regulation of the c-Abl and Bcr-Abl tyrosine kinases. Nat Rev Mol Cell Biol 2004; 5: 33\u201344.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFleu201653_CR2","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1073\/pnas.0510423103","volume":"103","author":"JP Radich","year":"2006","unstructured":"Radich JP, Dai H, Mao M, Oehler V, Schelter J, Druker B et al. Gene expression changes associated with progression and response in chronic myeloid leukemia. Proc Natl Acad Sci USA 2006; 103: 2794\u20132799.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu201653_CR3","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/sj.leu.2404227","volume":"20","author":"C Zheng","year":"2006","unstructured":"Zheng C, Li L, Haak M, Brors B, Frank O, Giehl M et al. Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis. Leukemia 2006; 20: 1028\u20131034.","journal-title":"Leukemia"},{"key":"BFleu201653_CR4","doi-asserted-by":"publisher","first-page":"6660","DOI":"10.1182\/blood-2010-08-304477","volume":"117","author":"CM Lucas","year":"2011","unstructured":"Lucas CM, Harris RJ, Giannoudis A, Copland M, Slupsky JR, Clark RE . Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression. Blood 2011; 117: 6660\u20136668.","journal-title":"Blood"},{"key":"BFleu201653_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cancergencyto.2010.09.001","volume":"204","author":"V Najfeld","year":"2011","unstructured":"Najfeld V . Development of t(8;21) and RUNX1-RUNX1T1 in the Philadelphia-positive clone of a patient with chronic myelogenous leukemia: additional evidence for multiple steps involved in disease progression. Cancer Genet 2011; 204: 165\u2013170.","journal-title":"Cancer Genet"},{"key":"BFleu201653_CR6","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1158\/0008-5472.CAN-10-4600","volume":"71","author":"RK Sachs","year":"2011","unstructured":"Sachs RK, Johnsson K, Hahnfeldt P, Luo J, Chen A, Hlatky L . A multicellular basis for the origination of blast crisis in chronic myeloid leukemia. Cancer Res 2011; 71: 2838\u20132847.","journal-title":"Cancer Res"},{"key":"BFleu201653_CR7","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.cellsig.2011.02.005","volume":"23","author":"O Yamada","year":"2011","unstructured":"Yamada O, Ozaki K, Furukawa T, Machida M, Wang YH, Motoji T et al. Activation of STAT5 confers imatinib resistance on leukemic cells through the transcription of TERT and MDR1. Cell Signal 2011; 23: 1119\u20131127.","journal-title":"Cell Signal"},{"key":"BFleu201653_CR8","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1182\/blood-2010-06-292433","volume":"117","author":"H Makishima","year":"2011","unstructured":"Makishima H, Jankowska AM, McDevitt MA, O'Keefe C, Dujardin S, Cazzolli H et al. CBL, CBLB, TET2, ASXL1, and IDH1\/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia. Blood 2011; 117: e198\u2013e206.","journal-title":"Blood"},{"key":"BFleu201653_CR9","doi-asserted-by":"publisher","first-page":"979","DOI":"10.4161\/cbt.10.10.14010","volume":"10","author":"LN Griner","year":"2010","unstructured":"Griner LN, Reuther GW . Aggressive myeloid leukemia formation is directed by the Musashi 2\/Numb pathway. Cancer Biol Ther 2010; 10: 979\u2013982.","journal-title":"Cancer Biol Ther"},{"key":"BFleu201653_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/leu.2010.236","volume":"25","author":"S Soverini","year":"2011","unstructured":"Soverini S, Score J, Iacobucci I, Poerio A, Lonetti A, Gnani A et al. IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis. Leukemia 2011; 25: 178\u2013181.","journal-title":"Leukemia"},{"key":"BFleu201653_CR11","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nature09171","volume":"466","author":"T Ito","year":"2010","unstructured":"Ito T, Kwon HY, Zimdahl B, Congdon KL, Blum J, Lento WE et al. Regulation of myeloid leukaemia by the cell-fate determinant Musashi. Nature 2010; 466: 765\u2013768.","journal-title":"Nature"},{"key":"BFleu201653_CR12","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1182\/blood-2013-01-476747","volume":"123","author":"F Nakahara","year":"2014","unstructured":"Nakahara F, Kitaura J, Uchida T, Nishida C, Togami K, Inoue D et al. Hes1 promotes blast crisis in chronic myelogenous leukemia through MMP-9 upregulation in leukemic cells. Blood 2014; 123: 3932\u20133942.","journal-title":"Blood"},{"key":"BFleu201653_CR13","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1182\/blood-2013-10-536078","volume":"123","author":"H Herrmann","year":"2014","unstructured":"Herrmann H, Sadovnik I, Cerny-Reiterer S, R\u00fclicke T, Stefanzl G, Willmann M et al. Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia. Blood 2014; 123: 3951\u20133962.","journal-title":"Blood"},{"key":"BFleu201653_CR14","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1182\/blood-2013-07-511907","volume":"123","author":"KP Ng","year":"2014","unstructured":"Ng KP, Manjeri A, Lee KL, Huang W, Tan SY, Chuah CT et al. Physiologic hypoxia promotes maintenance of CML stem cells despite effective BCR-ABL1 inhibition. Blood 2014; 123: 3316\u20133326.","journal-title":"Blood"},{"key":"BFleu201653_CR15","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.4161\/cc.8.9.8209","volume":"8","author":"SA Stuart","year":"2009","unstructured":"Stuart SA, Minami Y, Wang JY . The CML stem cell: evolution of the progenitor. Cell Cycle 2009; 8: 1338\u20131343.","journal-title":"Cell Cycle"},{"key":"BFleu201653_CR16","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1038\/leu.2010.159","volume":"24","author":"I Sloma","year":"2010","unstructured":"Sloma I, Jiang X, Eaves AC, Eaves CJ . Insights into the stem cells of chronic myeloid leukemia. Leukemia 2010; 24: 1823\u20131833.","journal-title":"Leukemia"},{"key":"BFleu201653_CR17","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.1182\/blood-2010-02-270660","volume":"116","author":"A Rizo","year":"2010","unstructured":"Rizo A, Horton SJ, Olthof S, Dontje B, Ausema A, van Os R et al. BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells. Blood 2010; 116: 4621\u20134630.","journal-title":"Blood"},{"key":"BFleu201653_CR18","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1084\/jem.20110304","volume":"208","author":"C Hurtz","year":"2011","unstructured":"Hurtz C, Hatzi K, Cerchietti L, Braig M, Park E, Kim YM et al. BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia. J Exp Med 2011; 208: 2163\u20132174.","journal-title":"J Exp Med"},{"key":"BFleu201653_CR19","doi-asserted-by":"publisher","first-page":"17967","DOI":"10.1073\/pnas.0808303105","volume":"105","author":"Y Minami","year":"2008","unstructured":"Minami Y, Stuart SA, Ikawa T, Jiang Y, Banno A, Hunton IC et al. BCR-ABL-transformed GMP as myeloid leukemic stem cells. Proc Natl Acad Sci USA 2008; 105: 17967\u201317972.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu201653_CR20","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1182\/blood-2007-02-073031","volume":"110","author":"SJ Neering","year":"2007","unstructured":"Neering SJ, Bushnell T, Sozer S, Ashton J, Rossi RM, Wang PY et al. Leukemia stem cells in a genetically defined murine model of blast-crisis CML. Blood 2007; 110: 2578\u20132585.","journal-title":"Blood"},{"key":"BFleu201653_CR21","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1056\/NEJMoa040258","volume":"351","author":"CH Jamieson","year":"2004","unstructured":"Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL et al. Granulocyte\u2013macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 2004; 351: 657\u2013667.","journal-title":"N Engl J Med"},{"key":"BFleu201653_CR22","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/sj.leu.2404657","volume":"21","author":"A Sengupta","year":"2007","unstructured":"Sengupta A, Banerjee D, Chandra S, Banerji SK, Ghosh R, Roy R et al. Deregulation and cross talk among Sonic hedgehog, Wnt, Hox and Notch signaling in chronic myeloid leukemia progression. Leukemia 2007; 21: 949\u2013955.","journal-title":"Leukemia"},{"key":"BFleu201653_CR23","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1158\/0008-5472.CAN-07-2509","volume":"68","author":"J Si","year":"2008","unstructured":"Si J, Collins SJ . Activated Ca2+\/calmodulin-dependent protein kinase IIgamma is a critical regulator of myeloid leukemia cell proliferation. Cancer Res 2008; 68: 3733\u20133742.","journal-title":"Cancer Res"},{"key":"BFleu201653_CR24","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1172\/JCI30779","volume":"117","author":"J Si","year":"2007","unstructured":"Si J, Mueller L, Collins SJ . CaMKII regulates retinoic acid receptor transcriptional activity and the differentiation of myeloid leukemia cells. J Clin Invest 2007; 117: 1412\u20131421.","journal-title":"J Clin Invest"},{"key":"BFleu201653_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.leukres.2005.05.023","volume":"30","author":"R Xu","year":"2006","unstructured":"Xu R, Dong Q, Yu Y, Zhao X, Gan X et al. Berbamine: a novel inhibitor of bcr\/abl fusion gene with potent anti-leukemia activity. Leuk Res 2006; 30: 17\u201323.","journal-title":"Leuk Res"},{"key":"BFleu201653_CR26","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1016\/j.ejmech.2009.02.018","volume":"44","author":"J Xie","year":"2009","unstructured":"Xie J, Ma T, Gu Y, Zhang X, Qiu X, Zhang L et al. Berbamine derivatives: a novel class of compounds for anti-leukemia activity. Eur J Med Chem 2009; 44: 3293\u20133298.","journal-title":"Eur J Med Chem"},{"key":"BFleu201653_CR27","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.1182\/blood-2012-06-434894","volume":"120","author":"Y Gu","year":"2012","unstructured":"Gu Y, Chen T, Meng Z, Gan Y, Xu X, Lou G et al. CaMKII\u03b3, a critical regulator of CML stem\/progenitor cells, is a target of the natural product berbamine. Blood 2012; 120: 4829\u20134839.","journal-title":"Blood"},{"key":"BFleu201653_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/leu.2008.262","volume":"23","author":"Y Hu","year":"2009","unstructured":"Hu Y, Chen Y, Douglas L, Li S . \u03b2-Catenin is essential for survival of leukemia stem cells in sensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia. Leukemia 2009; 23: 109\u2013116.","journal-title":"Leukemia"},{"key":"BFleu201653_CR29","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.ccr.2007.11.003","volume":"12","author":"C Zhao","year":"2007","unstructured":"Zhao C, Blum J, Chen A, Kwon HY, Jung SH, Cook JM et al. Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 2007; 12: 528\u2013541.","journal-title":"Cancer Cell"},{"key":"BFleu201653_CR30","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/leu.2010.24","volume":"24","author":"S Chu","year":"2010","unstructured":"Chu S, McDonald T, Bhatia R . Role of BCR-ABL-Y177-mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors. Leukemia 2010; 24: 779\u2013787.","journal-title":"Leukemia"},{"key":"BFleu201653_CR31","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1080\/15384101.2015.1041692","volume":"14","author":"MV Jain","year":"2015","unstructured":"Jain MV, Jangamreddy JR, Grabarek J, Schweizer F, Klonisch T, Cie\u015blar-Pobuda A et al. Nuclear localized Akt enhances breast cancer stem-like cells through counter-regulation of p21(Waf1\/Cip1) and p27(kip1). Cell Cycle 2015; 14: 2109\u20132120.","journal-title":"Cell Cycle"},{"key":"BFleu201653_CR32","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.molonc.2013.07.011","volume":"7","author":"J Zhang","year":"2013","unstructured":"Zhang J, Seet CS, Sun C, Li J, You D, Volk A et al. p27kip1 maintains a subset of leukemia stem cells in the quiescent state in murine MLL-leukemia. Mol Oncol 2013; 7: 1069\u20131082.","journal-title":"Mol Oncol"},{"key":"BFleu201653_CR33","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.ccr.2013.03.012","volume":"23","author":"W Zhang","year":"2013","unstructured":"Zhang W, Tan W, Wu X, Poustovoitov M, Strasner A, Li W, Borcherding N et al. A NIK-IKK\u03b1 module expands ErbB2-induced tumor-initiating cells by stimulating nuclear export of p27\/Kip1. Cancer Cell 2013; 23: 647\u2013659.","journal-title":"Cancer Cell"},{"key":"BFleu201653_CR34","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1101\/gad.1556607","volume":"21","author":"A Besson","year":"2007","unstructured":"Besson A, Hwang HC, Cicero S, Donovan SL, Gurian-West M, Johnson D et al. Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype. Genes Dev 2007; 21: 1731\u20131746.","journal-title":"Genes Dev"},{"key":"BFleu201653_CR35","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.4161\/cc.10.9.15421","volume":"10","author":"C Mench\u00f3n","year":"2011","unstructured":"Mench\u00f3n C, Edel MJ, Izpisua Belmonte JC . The cell cycle inhibitor p27Kip1 controls self-renewal and pluripotency of human embryonic stem cells by regulating the cell cycle, Brachyury and Twist. Cell Cycle 2011; 10: 1435\u20131447.","journal-title":"Cell Cycle"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201653.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201653","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201653.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T17:20:09Z","timestamp":1648747209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,8]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["BFleu201653"],"URL":"https:\/\/doi.org\/10.1038\/leu.2016.53","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,8]]},"assertion":[{"value":"29 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}